0001493152-23-039336.txt : 20231103
0001493152-23-039336.hdr.sgml : 20231103
20231103164948
ACCESSION NUMBER: 0001493152-23-039336
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231101
FILED AS OF DATE: 20231103
DATE AS OF CHANGE: 20231103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CONRAD HERBERT J
CENTRAL INDEX KEY: 0001218815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38022
FILM NUMBER: 231377082
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA CORP.
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc.
CENTRAL INDEX KEY: 0001582554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463011414
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
BUSINESS PHONE: 908-484-8805
MAIL ADDRESS:
STREET 1: 1545 ROUTE 206 SOUTH
STREET 2: SUITE 302
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
4
1
ownership.xml
X0508
4
2023-11-01
0
0001582554
Matinas BioPharma Holdings, Inc.
MTNB
0001218815
CONRAD HERBERT J
C/O MATINAS BIOPHARMA HOLDINGS, INC.
1545 ROUTE 206 SOUTH SUITE 302
BEDMINSTER
NJ
07921
1
0
0
0
0
Stock option (right to buy)
0.2088
2023-11-01
4
A
0
437244
0
A
2033-11-01
Common Stock
437244
437244
D
The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on November 1, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.
/s/ Keith A. Kucinski, attorney-in fact for Herbert J. Conrad
2023-11-03